1 - 9 |
Superantibodies - Synergy of innate and acquired immunity Kohler H |
13 - 28 |
Tracking immunoglobulin variable-gene expression in HIV infection Zouali M |
31 - 49 |
Epitope promiscuity of human monoclonal autoantibodies to T-cell receptor-combining site determinants Marchalonis JJ, Robey I, Schluter SF, Yocum DE |
53 - 60 |
Diversification and selection mechanisms for the production of protein repertoires - Lessons from the immune system Neuberger MS, Sale JE, Cumbers SJ, Jolly CJ, Bemark MP, Ehrenstein MR, Lanoue A, Bruggemann M, Batista FD, Davies SL, Williams GT |
63 - 70 |
Structural components responsible for peptide antigenicity Sela M |
71 - 82 |
Natural catalytic immunity is not restricted to autoantigenic substrates - Identification of a human immunodeficiency virus gp 120-cleaving antibody light chain Paul S, Kalaga RS, Gololobov G, Brenneman D |
85 - 92 |
Does catalytic activity of Bence-Jones proteins contribute to the pathogenesis of multiple myeloma? Sinohara H, Matsuura K |
95 - 103 |
DNA hydrolysis by monoclonal autoantibody BV 04-01 Rodkey LS, Gololobov G, Rumbley CA, Rumbley J, Schourov DV, Makarevich OI, Gabibov AG, Voss EW |
107 - 113 |
Amidase and peptidase activities of polyclonal immunoglobulin G present in the sera of patients with rheumatoid arthritis Matsuura K, Ikoma S, Sugiyama M, Funauchi M, Sinohara H |
115 - 129 |
Secretory immunoglobulin A from healthy human mothers' milk catalyzes nucleic acid hydrolysis Nevinsky GA, Kanyshkova TG, Semenov DV, Vlassov AV, Gal'vita AV, Buneva VN |
131 - 144 |
Localization of a novel adhesion-promoting site on acetylcholinesterase using catalytic antiacetylcholinesterase antibodies displaying cholinesterase-like activity Johnson G, Moore SW |
155 - 162 |
Idiotypic network dysregulation - A common etiopathogenesis of diverse autoimmune diseases Sherer Y, Shoenfeld Y |
163 - 169 |
Catalytic mechanism of an abzyme displaying a beta-lactamase-like activity Avalle B, Debat H, Friboulet A, Thomas D |
173 - 180 |
Nonspecific catalysis by protein surfaces Kirby AJ, Hollfelder F, Tawfik DS |
183 - 190 |
Pyridoxal-5'-phosphate-dependent catalytic antibodies Gramatikova SI, Christen P |
195 - 206 |
Catalytic antibodies for complex reactions - Hapten design and the importance of screening for catalysis in the generation of catalytic antibodies for the NDA/CN reaction DeSilva BS, Orosz G, Egodage KL, Carlson RG, Schowen RL, Wilson GS |
209 - 219 |
How and why 41S-2 antibody subunits acquire the ability to catalyze decomposition of the conserved sequence of gp41 of HIV-1 Hifumi E, Okamoto Y, Uda T |
221 - 231 |
Nucleophilic proteolytic antibodies Gololobov G, Tramontano A, Paul S |
233 - 242 |
Inhibition and labeling of enzymes and abzymes by phosphonate diesters Tramontano A, Ivanov B, Gololobov G, Paul S |
245 - 251 |
Autoantibodies to thyroglobulin in health and disease Rose NR, Burek CL |
255 - 268 |
Autoantibodies to nuclear antigens - Correlation between cytotoxicity and DNA-hydrolyzing activity Kozyr AV, Kolesnikov AV, Zelenova NA, Sashchenko LP, Mikhalap SV, Bulina ME, Ignatova AN, Favorov PV, Gabibov AG |
271 - 283 |
Multifunctional antigens of A-fumigatus and specific antibodies Purkayastha S, Madan T, Shah A, Krishnamurthy HG, Sarma PU |
287 - 294 |
A preliminary study for isolation of catalytic antibodies by histidine ligand affinity chromatography as an alternative to conventional protein A/G methods Nedonchelle E, Pitiot O, Vijayalakshmi MA |